BioMatrix Alpha
by Biosensors Europe SA 24 variants
Ref BMX6-2733Model BMX6-2209
Active
CE MDR CE MDD
Valid until
12 Mar 2031
FDA recalls
Not applicable
Documents
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR | Number745.151 | Date13 Mar 2026 | StatusActive |
| European Union | CE/MDD | NumberB-08888893018812 08888893018812 | Date12 Jun 2023 | StatusActive |
Certificates
- 745.151 Active
Quality management system EU MDR
- Certifier
- National Standards Authority of Ireland (NSAI) 0050
- Issued
- 13 Mar 2026
- Expires
- 12 Mar 2031
- TD745.151 Active
Technical documentation EU MDR
- Certifier
- National Standards Authority of Ireland (NSAI) 0050
- Issued
- 13 Mar 2026
- Expires
- 12 Mar 2031
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/MDR, CE/MDD Active
Specification
- Trade Name
- BioMatrix Alpha Drug Eluting Coronary Stent System
- Device Name
- BioMatrix Alpha
- Model / Reference
- BMX6-2733, BMX6-2209
- Primary DI / UDI-DI
- 08888893018812
- Basic UDI-DI
- B-08888893018812, 8888893BMX6HV
- EMDN Code
- P070402010301 Coronary drug eluting stents (des) with polymers
- Device Class
- Class III
- EU market of registration
- Netherlands
Manufacturer details
- EUDAMED SRN
- CH-MF-000015764
- Authorised representative
- NVT GmbH DE-AR-000006441
Other devices from Biosensors Europe SA
Properties
Other properties (9)
- Reusable: No
- Contains Latex: No
- Reprocessed: No
- Human-derived: No
- Human Tissues: No
- Animal Tissues: No
- Endocrine Disruptor: No
- Administering Medicine: No
- Measuring Function: No